BioNTech
(NASDAQ:BNTX)
$93.39
1.15[1.25%]
At close: May 3
$93.39
0[0.00%]
After Hours: 7:55PM EDT
Q1 2024 earnings tomorrow on Mon May 6th before the market open
Conference call scheduled tomorrow at 8:00 AM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

BioNTech Stock (NASDAQ:BNTX), Quotes and News Summary

BioNTech Stock (NASDAQ: BNTX) stock price, news, charts, stock research, profile.

Open$93.420
Close$92.720
Volume / Avg.663.327K / 585.252K
Day Range91.600 - 93.540
52 Wk Range85.213 - 125.830
Market Cap$22.506B
P/E Ratio22.579
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest
6.01%
Days to Cover3.71

Recent News

GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Specialty Medicines, propelled by strong demand for Arexvy and Shingrix. Expectations soar with raised 2024 EPS and sales forecasts.
Vandana Singh
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent infringement in mRNA technology.
Vandana Singh
What's Going On With Pfizer Stock On Thursday?
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S.
Vandana Singh
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
4
1
Feb
2
1
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BNTX
LEGN

FAQ

Q

How do I buy BioNTech (BNTX) stock?

A

You can purchase shares of BioNTech (NASDAQ: BNTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BioNTech's (BNTX) competitors?

A

Other companies in BioNTech’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for BioNTech (BNTX) stock?

A

The latest price target for BioNTech (NASDAQ: BNTX) was reported by HC Wainwright & Co. on Wednesday, April 17, 2024. The analyst firm set a price target for 107.00 expecting BNTX to rise to within 12 months (a possible 14.57% upside). 36 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BioNTech (BNTX)?

A

The stock price for BioNTech (NASDAQ: BNTX) is $93.39 last updated May 3, 2024 at 7:55 PM EDT.

Q

Does BioNTech (BNTX) pay a dividend?

A

There are no upcoming dividends for BioNTech.

Q

When is BioNTech (NASDAQ:BNTX) reporting earnings?

A

BioNTech’s Q1 earnings are confirmed for Monday, May 6, 2024.

Q

Is BioNTech (BNTX) going to split?

A

There is no upcoming split for BioNTech.

Q

What sector and industry does BioNTech (BNTX) operate in?

A

BioNTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch